Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Strategies for treating HIV-related lipodystrophy.

M A García-Viejo1, M Ruíz, E Martínez

  • 1Infectious Diseases Unit, Clinical Institute of Infectious Diseases and Immunology, IDIBAPS-Hospital Clinic University, C/Villarroel, 170, E-08036-Barcelona, Spain.

Expert Opinion on Investigational Drugs
|January 5, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neural processing to visual stimuli in a three-choice reaction-time task.

Brain and cognition·2001
Same author

Polyamine metabolism and glutamate receptor agonists-mediated excitotoxicity in the rat brain.

Journal of neuroscience research·2001
Same author

Adult and nymphs of Microtriatoma trinidadensis (Lent, 1951) (Hemiptera: Reduviidae) caught from peridomestic environment in Bolivia.

Memorias do Instituto Oswaldo Cruz·2001
Same author

Massive upper gastrointestinal bleeding as a manifestation of somatostatinoma of the ampulla of vater.

Digestive diseases and sciences·2001
Same author

A first case of cutaneous leishmaniasis due to Leishmania (Viannia) lainsoni in Bolivia.

Transactions of the Royal Society of Tropical Medicine and Hygiene·2001
Same author

Arterioenteric fistula due to cytomegalovirus infection after pancreas transplantation.

Transplantation·2001

HIV-related lipodystrophy, a common issue in chronic HIV infection, has unknown causes and treatments. Management requires an individualized approach due to multifactorial etiology and limited therapeutic success.

Area of Science:

  • Infectious Diseases
  • Endocrinology
  • Public Health

Background:

  • HIV infection is now a chronic disease, leading to prevalent complications like lipodystrophy.
  • HIV-related lipodystrophy significantly impacts patient quality of life and increases cardiovascular risk.
  • The aetiopathogenesis, diagnosis, prevention, and therapy of lipodystrophy remain largely unexplored.

Purpose of the Study:

  • To review the current understanding of HIV-related lipodystrophy.
  • To discuss the multifactorial aetiology, diagnostic challenges, and therapeutic options.
  • To emphasize the need for an individualized management strategy.

Main Methods:

  • Literature review of current evidence on HIV-related lipodystrophy.
  • Analysis of contributing factors including HIV infection, antiretroviral therapy, and patient-related elements.

Related Experiment Videos

  • Evaluation of various therapeutic strategies and their limitations.

    • Main Results:

    • Lipodystrophy etiology is multifactorial, involving HIV, antiretroviral therapy, and patient factors.
    • Diagnosis is hindered by the lack of a formal definition and co-existing wasting syndromes.
    • Therapeutic approaches show limited success and require careful consideration of potential complications.

    Conclusions:

    • HIV-related lipodystrophy is a significant challenge in chronic HIV management.
    • Current therapeutic options are limited, necessitating an individualized and judicious approach.
    • Further research is crucial to understand and effectively manage lipodystrophy and its associated metabolic risks.